英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
Moling查看　Moling　在百度字典中的解释百度英翻中〔查看〕
Moling查看　Moling　在Google字典中的解释Google英翻中〔查看〕
Moling查看　Moling　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Biologics for eosinophilic oesophagitis: a systematic review and meta . . .
    Abstract Objective Advancing the understanding of the pathophysiology of eosinophilic oesophagitis (EoE) and other eosinophilic gastrointestinal diseases (EGIDs) has spurred research into targeted biological therapies, while the conclusive therapeutic efficacy of biologics remains uncertain In this review, we conducted a meta-analysis of all RCTS of biologics in the treatment of EoE to
  • Current state of biologics in treating eosinophilic esophagitis
    Eosinophilic esophagitis (EoE) is a chronic, allergen-mediated, eosinophil-predominant, type 2 inflammatory disease that progresses to fibrostenosis of the esophagus if left untreated This review focuses on biologics therapy in EoE
  • Biologics in the Treatment of Eosinophilic Esophagitis: Ready for Use?
    Eosinophilic esophagitis (EoE) is a chronic disease mediated by environmental allergens and type 2 immune inflammation, which causes significant symptoms including dysphagia and food impaction 1,2 The incidence and prevalence of EoE are rising and untreated disease can lead to significant esophageal stenosis 2,3 Standard treatments include proton-pump inhibitors (PPIs), swallowed topical
  • Biologics in eosinophilic esophagitis - PubMed
    Biologics for treatment of EoE may result in symptom and histologic improvement and has the potential to treat disease with minimal side effects
  • DUPIXENT® (dupilumab) For Eosinophilic Esophagitis
    Learn more about DUPIXENT® (dupilumab), the first FDA-approved biologic to treat eosinophilic esophagitis (EoE) in adult and pediatric patients aged 1 year and older who weigh at least 33lb (15kg) Serious side effects can occur Please see Important Safety Information and Prescribing Information and Patient Information on website
  • Biologics in Eosinophilic Esophagitis — Ready for Prime Time?
    Eosinophilic esophagitis is an immune-mediated, chronic, inflammatory disease of the esophagus that was first recognized as a distinct entity less than three decades ago 1 The immunopathogenesis of
  • Eosinophilic esophagitis: promising therapy, biomarkers, and assessment . . .
    The recent approval of dupilumab for treatment of eosinophilic esophagitis (EOE), research into better biomarkers, and the anticipated availability of a metric to assess EOE severity all bode well for patients Speakers considered the ramifications of these developments Breakthroughs in biologic therapy for eosinophilic esophagitis Biologics and other novel therapies are needed for treatment
  • Consumer’s Guide to Biologics for Eosinophilic Esophagitis
    The Consumer’s Guide to Biologics for Eosinophilic Esophagitis Learn everything you need to know about the first FDA-approved treatment for eosinophilic esophagitis
  • Biological Therapies for Eosinophilic Gastrointestinal Diseases
    The identification of novel biologic strategies is ongoing, and the recent validation of instruments and outcome measures to assess disease activity has proved essential in demonstrating efficacy Studies using biologics that target IL-13 pathways in the treatment of EoE have demonstrated substantial promise
  • The Dupixent as a Treatment for Eosinophilic Esophagitis
    The Role of Dupixent in Treating Eosinophilic Esophagitis Dupixent is essential in treating eosinophilic esophagitis (EoE), a chronic esophageal inflammation As a biologic anti-inflammatory, it helps decrease inflammation and alleviate related symptoms efficiently





中文字典-英文字典  2005-2009